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 • NEURORADIOLOGY
Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease characterized by progressive 
damage to the motor system leading to irreversible pa-
ralysis of spinal and bulbar muscles, often accompanied 
or followed by cognitive dysfunction, with some clinical 
ALS presentations also meeting criteria for frontotempo-
ral dementia (FTD) (1). The histopathologic hallmark 
of ALS—phosphorylated 43kDa TAR DNA-binding 
protein (pTDP-43) (2)—appears to involve primarily 
the motor nuclei of cranial nerves V, VII, and X-XII, the 
primary motor cortex, and the spinal cord. Early patho-
logic burden has also been identified in the reticular for-
mation, red nucleus, and prefrontal cortex, as well as in 
the prefrontal, postcentral and striatal regions, with ad-
vanced disease also often involving temporal lobe regions, 
including the hippocampus (3).
The topographic distribution of pTDP-43 inclusions 
may, however, not necessarily be the only explanation for 
neurodegeneration; a further potentially relevant process 
is the mismanagement of metals such as iron or copper 
(4). Recent work in mouse models has demonstrated that 
iron chelation can decrease pathologic protein aggregation, 
enhance antiapoptotic protein expression, delay disease 
onset, prevent motor neuron loss, and, overall, extend the 
rodents’ lifespans (5,6), reinforcing the view that brain iron 
might have an important role in ALS pathogenesis.
MRI is potentially ideal for monitoring metal lev-
els in vivo because of the impact that iron species have 
on magnetic susceptibility, a fundamental physical 
property that can be approximated by using a recently 
validated technique, quantitative susceptibility map-
ping (QSM) (7). QSM has shown potential to detect 
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Purpose: To investigate the whole-brain landscape of iron-related abnormalities in amyotrophic lateral sclerosis (ALS) by using the 
in vivo MRI technique of quantitative susceptibility mapping (QSM).
Materials and Methods: For this prospective study, 28 patients with ALS (mean age, 61 years; age range, 43–77 years; 18 men [mean 
age, 61 years; range, 43–77 years] and 10 women [mean age, 61 years; range, 47–74 years]) recruited between January 17, 2014, 
and September 4, 2015, and 39 matched control subjects (mean age, 61 years; age range, 39–77 years; 24 men [mean age, 62 years; 
range, 39–77 years] and 15 women [mean age, 59 years; range, 39–73 years]) were examined by using structural and susceptibility 
3.0-T MRI techniques. Group data were cross sectionally compared with family-wise error (FWE) corrections by using voxel-based 
morphometry (random-field theory), cortical thickness analysis (Monte Carlo simulated), subcortical volumetry (Bonferroni-
corrected Wilcoxon rank-sum testing), and QSM analysis (cluster-enhanced whole-brain permutation testing and Bonferroni-
corrected rank-sum testing in regions of interest). In patients with ALS, a potential relationship between diffusion and susceptibility 
measurements in the corticospinal tracts (CSTs) was also examined by using Spearman rank-correlation tests.
Results: Conventional structural measures failed to identify atrophy in the present cohort (FWE P . .05). However, QSM identi-
fied several whole-brain abnormalities (FWE P , .05) in ALS. Regionally, higher susceptibility (expressed as means in parts per 
million 6 standard errors of the mean) was confirmed in the motor cortex (ALS = 0.0188 6 0.0003, control = 0.0173 6 0.0003; 
P < .001), the left substantia nigra (ALS = 0.127 6 0.004, control = 0.113 6 0.003; P = .008), the right substantia nigra (ALS 
= 0.141 6 0.005, control = 0.120 6 0.003; P < .001), the globus pallidus (ALS = 0.086 6 0.003, control = 0.075 6 0.002; P = 
.003), and the red nucleus (ALS = 0.115 6 0.004, control = 0.098 6 0.003; P < .001). Lower susceptibility was found in CST 
white matter (ALS = 20.047 6 0.001, control = 20.043 6 0.001; P = .01). Nigral and pallidal QSM values were cross correlated 
in ALS (r2 = 0.42, P < .001), a phenomenon visually traceable in many individual patients. QSM in the CST in ALS also correlated 
with diffusion-tensor metrics in this tract (r2 = 0.25, P = .007).
Conclusion: Whole-brain MRI quantitative susceptibility mapping analysis is sensitive to tissue alterations in amyotrophic lateral 
sclerosis that may be relevant to pathologic changes.
© RSNA, 2018
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Abbreviations
ALS = amyotrophic lateral sclerosis, ALSFRS-R = ALS Functional Rating 
Scale Revised, CST = corticospinal tract, DTI = diffusion-tensor imaging, 
ECAS = Edinburgh Cognitive and Behavioral ALS Screen, FTD = fron-
totemporal dementia, FWE = family-wise error, GP = globus pallidus, 
MoCA = Montreal Cognitive Assessment, pTDP-43 = phosphorylated 
43kDa TAR DNA-binding protein, QSM = quantitative susceptibility 
mapping, ROI = region of interest, SN = substantia nigra
Summary
Quantitative susceptibility mapping alterations in amyotrophic lateral 
sclerosis involve the motor cortex, corticospinal tracts, and a range of 
subcortical nuclei. This distribution is consistent with the known pat-
tern of brain degeneration in this disease.
Implications for Patient Care
 n There is a distinct pattern of iron deposition in amyotrophic lateral 
sclerosis (ALS) that can be identified by using quantitative suscep-
tibility mapping MRI.
 n Susceptibility measurements in ALS were abnormal in the motor 
cortex, corticospinal tracts, and a range of subcortical nuclei.
 n Abnormalities consistent with iron deposition are present in areas 
of the brain that have been previously associated with neurodegen-
eration in ALS.
iron-related motor cortex alterations in ALS and other mo-
tor neuron disorders (8). However, the global distribution of 
abnormal QSM levels in ALS and its significance relative to 
standard structural MRI markers has not yet been elucidated. 
We hypothesized that whole-brain QSM would capture a 
distribution of perturbations in iron concentration preferen-
tially affecting the central nervous system structures relevant 
to the motor system in this disease.
Materials and Methods
Study Participants
The local ethics committee approved our prospective study 
(140/14), with all subjects giving written informed consent 
prior to their inclusion. A cohort of patients with ALS (mean 
age, 61 years; age range, 43–77 years; 18 men [mean age, 61 
years; range, 43–77 years] and 10 women [mean age, 61 years; 
range, 47–74 years]) recruited between January 17, 2014, and 
September 4, 2015 (by S.V., an ALS specialist with 25 years 
of experience), were grouped into disease phenotypes accord-
ing to recently specified criteria based on results of clinical 
examination (9) and electromyography (10). At the time of 
MRI assessment, 28 patients displayed a variable combination 
of upper motor neuron signs (spasticity, clonus, pathologically 
brisk reflexes, pyramidal signs) and lower motor neuron signs 
(wasting, weakness, fasciculations) in the upper and lower 
limbs, in turn fulfilling the El Escorial criteria for definite or 
probable ALS (11). As summarized in Figure 1, patients with 
bulbar phenotype or pure upper motor neuron disease variants 
(also comprising primary lateral sclerosis and pure lower motor 
neuron disease variants including flail arm, flail limb, and pro-
gressive muscular atrophy) were excluded, as were those with 
concomitant FTD; the latter was defined on clinical grounds 
(including caregiver reports) in accordance with proposed di-
Figure 1: Summary of patient recruitment and 
exclusions.
agnostic criteria (12). Furthermore, there were no patients with 
primary progressive aphasia. Patients’ functional and general 
cognitive status was assessed by using the ALS Functional Rat-
ing Scale Revised (ALSFRS-R) and the Edinburgh Cognitive 
and Behavioral ALS Screen (ECAS) and Montreal Cognitive 
Assessment (MoCA), respectively. Genetic testing for identi-
fication of C9orf72 (chromosome 9 open reading frame 72) 
expansion carriers and SOD1 (superoxide dismutase 1) mu-
tation carriers was performed in 20 (71%) patients and iden-
tified two patients (approximately 10%) with the C9orf72 
gene expansion. Thirty-nine healthy control subjects were 
carefully selected for imaging comparisons by individual 
age and sex matching (mean age, 61 years; age range, 39–
77 years; 24 men [mean age, 62 years; range, 39–77 years] 
and 15 women [mean age, 59 years; range, 39–73 years]). 
All control subjects were free of neurologic illness and per-
formed normally on cognitive screening tests (Mini-Mental 
State Examination score  28). All demographic details are 
summarized in the Table.
Imaging Protocol
MRI measurements were performed on a Siemens Verio 3.0-T 
system with a 32-channel head coil for reception (Siemens Medi-
cal Systems, Erlangen, Germany). Susceptibility MRI was per-
formed with a three-dimensional, fully flow-compensated, spoiled 
gradient-echo pulse sequence with the following parameters: flip 
angle, 17°; echo time msec/repetition time msec, 20/28; and re-
ceiver bandwidth, 100 Hz/pixel. Reconstruction matrix dimen-
sions were 256 3 224 3 80, with a voxel resolution of 1 3 1 3 
2 mm3. Parallel imaging was enabled, with two-fold acceleration 
yielding an imaging time of 5 minutes 32 seconds.
T1-weighted magnetization-prepared rapid gradient-echo 
anatomic images were also acquired with the following param-
eters: inversion time, 1100 msec; flip angle, 7°; 4.82/2500; 
and bandwidth = 140 Hz/pixel. Matrix dimensions were 256 
3 256 3 192 (7/8 phase partial Fourier), with a voxel size 
of 1 3 1 3 1 mm3. Parallel imaging was also enabled with 
two-fold acceleration.
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Table 1: Study Demographic Details
Characteristic Control Subjects (n = 39) Patients with ALS (n = 28) P Value
Male:female ratio 24:15 18:10 .2
Age (y) 60.5 6 11.1 (39–77) 60.6 6 9.7 (43–77) .9
Age of male participants (y) 61.7 6 11.9 (39–77) 60.6 6 10.9 (43–77) .8
Age of female participants (y) 58.7 6 9.9 (39–73) 60.6 6 7.4 (47–74) .8
Site onset (limb:bulbar) NA 18:10
Disease duration (mo) NA 18 6 12 (4–64)
ALSFRS-R score (out of 48) NA 38.4 6 6.0 (26–48)
MoCA total score (out of 30) NA 24.6 6 3.2 (18–30)
ECAS total score (out of 136) NA 100 6 15.4 (58–123)
MMSE score (out of 30) 28.6 6 0.9 (28–30) NA
Note.—Where appropriate, values are given as means 6 standard deviations, with ranges in parentheses. ALS = amyotrophic lateral sclero-
sis, ALSFRS-R = ALS Functional Rating Scale Revised, ECAS = Edinburgh Cognitive and Behavioral ALS Screen, MMSE = Mini-Mental 
State Examination, MoCA = Montreal Cognitive Assessment, NA = not applicable.
Diffusion MRI data were acquired by using a twice-refo-
cused single-shot echo-planar imaging pulse sequence with 
81/12700 ms, a matrix of 128 3 128, 72 sections, a voxel 
size of 2 3 2 3 2 mm3, and a bandwidth of 1628 Hz/pixel. 
A sequence of 30 diffusion-weighted acquisitions (b = 1000 
sec/mm2) with diffusion encoding along 30 noncollinear ori-
entations (Siemens “MDDW” shell) and two interleaved ref-
erence acquisitions was repeated twice. Parallel imaging was 
enabled (three-fold acceleration), for a total imaging time of 
14 minutes 11 seconds.
The image acquisition protocol was optimized by J.A. and 
J.K., physicists with 15 and 20 years of experience in MRI re-
search, respectively.
Data Reconstruction and Postprocessing
Structural MRI.—The following standard methods for voxel-
based morphometry, cortical thickness measurements, and 
subcortical volumetry were applied: SPM12b v6080 (http://
www.fil.ion.ucl.ac.uk/spm), FreeSurfer v5.3.0 (http://surfer.nmr.
mgh.harvard.edu), and FSL v5.0.9 processing tools (https://fsl.
fmrib.ox.ac.uk/fsl/fslwiki/FIRST), respectively.
Susceptibility MRI.—Coil-specific data were combined by us-
ing a modified adaptive algorithm (13,14). Combined phase 
images were then "unwrapped" with a Laplacian approach 
(15), and the local field was revealed by means of spherical 
mean-value filtering (16) using a kernel radius of 5 mm. Sus-
ceptibility maps were then estimated by using the nonlinear 
morphology–enabled dipole inversion algorithm (17) with the 
regularization parameter set to an empirically optimized value 
of l = 1000. To avoid assumptions about areas being spared 
in ALS, QSM values were not referenced. Susceptibility maps 
were spatially standardized with the aid of T1-weighted data 
by using a previously described ANTs v2.1.0 routine (http://
stnava.github.io/ANTs) (14).
Diffusion MRI.—Diffusion-tensor imaging (DTI) was pro-
cessed with standard FSL tools (https://fsl.fmrib.ox.ac.uk/fsl/
fslwiki/TBSS), resulting in whole-brain skeletonized fractional 
anisotropy and mean, radial, and axial diffusivity data for each 
participant.
Regional extractions.—Median QSM values were extracted 
bilaterally from major subcortical structures by applying 
the FSL-FIRST (FMRIB's Integrated Registration and Seg-
mentation Tool) algorithm to our anatomic study template. 
QSM data were also extracted from previously validated 
manual segmentations of the red nucleus, substantia nigra 
(SN), and cerebellar dentate nucleus (14). Further segmen-
tation of the SN was achieved through manual tracing of a 
(dorsal) T1-weighted hyperintense band highly colocalized 
with the anatomic site of the SN pars compacta. Finally, all 
subcortical regions of interest (ROIs) were eroded by convo-
lution with a 1-mm-radius spherical kernel. Cortical ROIs 
for the motor cortex (precentral gyrus) and the pars opercu-
laris of the inferior frontal gyrus were also examined; these 
were defined from a gyral-based digital atlas (http://www.
mindboggle.info/data.html) by using a previously proposed 
approach (18). Median DTI parameter values were calcu-
lated for the corticospinal tract (CST) by intersection with 
a standard digital atlas (http://cmrm.med.jhmi.edu). Subse-
quently, median QSM values (across the same skeletonized 
CST mask) were also extracted in studywise space. All ROIs 
investigated are illustrated in Figure 2. Data processing was 
performed by J.A. and N.S. (an imaging researcher with 8 
years of experience).
Statistical Analysis
Demographic analysis.—Sex and age differences between 
groups were assessed with a x2 test of independence and two-
sample Wilcoxon rank-sum tests, respectively.
Structural MRI analysis.—Between-group statistical compar-
isons were performed with standard methods and a family-wise 
error (FWE)-adjusted statistical cutoff of P , .05. SPM cor-
rects for FWE (both at voxel and cluster levels) by using ran-
dom-field theory. Freesurfer implements a cluster-wise Monte 
Carlo simulation procedure for FWE correction on surfaces. 
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and pars opercularis ROIs. For all other regions, QSM values 
were averaged across hemispheres. Subsequently, regional QSM 
values were age-corrected by using the covariance method (20), 
and cross-sectional QSM comparisons (ALS vs control subjects) 
were performed by using two-tailed Wilcoxon rank-sum tests. 
For ROIs returning cross-sectional alterations, Spearman rank 
correlation tests were then performed to explore a potential re-
lationship between QSM and clinical severity scores.
CST correlation study.—Because past ALS studies have reported 
fractional anisotropy abnormalities along the CSTs (21,22), 
we investigated whether QSM might be sensitive to the same 
underlying mechanisms detected with DTI. Spearman rank-
correlation tests were performed on the null hypothesis that 
QSM does not covary with DTI metrics in the ALS CST. All 
statistical analyses were performed by J.A.
Results
Structural measures—subcortical volumetry, voxel-based 
morphometry, and cortical thickness analysis—were all nega-
tive in age-corrected ALS-versus-control comparisons at 
FWE P , .05. The FWE-corrected absolute QSM results 
illustrated in Figure 3, however, revealed anatomically con-
fluent alterations selectively in the motor cortex (Montreal 
Neurologic Institute z = +26 to +68 mm) extensively across 
most of the motor cortex but also including premotor me-
dial areas and the primary somatosensory field; in the CST 
The Bonferroni procedure was used for FWE correction of 
deep gray matter volumetric measurements.
Whole-brain QSM analysis.—Absolute QSM data—used 
to prevent convolution-driven cancellations of spatially- 
adjacent positive/negative susceptibilities (19)—were smoothed 
(Gaussian kernel, standard deviation: 3 mm) and compensated 
for brain-boundary effects (19). On the assumption that age 
dispersion in our study (39–77 years old) could introduce 
spurious age-related QSM variance (14), the cross-sectional 
(ALS vs control) design included age as a nuisance covariate. 
Finally, whole-brain analysis was performed with threshold-
free cluster-enhanced permutation statistics by using FSL tools 
(http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/Randomise). Significant clus-
ters were inferred from 20 000 data permutations and were re-
ported at FWE P , .05. Subsequently after analysis, the QSM 
template and statistical maps were warped into MNI152 space 
(Montreal Neurologic Institute, McGill University, Canada) 
by using ANTs tools.
Regional QSM analysis.—Signed QSM data were regionally 
assessed to resolve the polarity of the QSM effects identified in 
the whole-brain study. In gray-matter ROIs, QSM distributions 
were not normally distributed; therefore, nonparametric statis-
tics were used throughout. QSM laterality effects in patients with 
ALS were probed by using Wilcoxon signed-rank tests; these re-
turned left/right differences (P , .001) for both SN subdivisions 
Figure 2: Images show selected regions of interest (ROIs) overlaid onto, A, T1-weighted and, B–G, quantitative susceptibil-
ity mapping study templates. A, B, Midbrain ROIs: dorsal/ventral substantia nigra subdivision and red nucleus. C, Cerebellar 
dentate nucleus. D, FIRST (FMRIB's Integrated Registration and Segmentation Tool) subcortical extractions. E, Precentral gyrus. 
F, Inferiofrontal pars opercularis. G, Corticospinal tract.
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values in ALS were identified at FWE P , .05. In addition, 
exploratory limb-versus-bulbar whole-brain comparisons were 
also negative at FWE P , .05. All results remained unchanged 
(FWE P , .05) when gene-mutation carriers were excluded.
Our age-corrected regional study confirmed the selective pat-
tern of QSM alterations in ALS (Fig 4). Our SN subdivision 
study revealed both dorsal (right: Z = 3.0, P = .003) and ventral 
(left: Z = 3.3, P = .001; right: Z = 3.2, P = .001) involvement 
in the form of higher signed QSM values in the ALS group, 
although with a ventral bias because of the relatively normal pro-
file observed for the left dorsal SN (Z = 1.4, P = .18). Signed 
QSM in the motor cortex (Z = 3.3, P < .001) and GP (Z = 3.0, 
at the level of the posterior limb of the internal capsule (z = 
–7 to +17 mm); in the posterior corpus striatum (z = –7 to 
+5 mm), centered primarily on the globus pallidus (GP) but 
also including the posterior putamen; in the mesencephalon (z 
= –16 to –7 mm), including the SN and red nucleus; and in 
the prefrontal cortex (z = –13 to +38 mm), most prominently 
in the pars opercularis of the inferior frontal region but also 
(albeit more patchy and less intense) in the middle prefrontal, 
orbitofrontal frontal pole, and left anterior temporal lobe. In 
contrast, QSM group differences in parietal (excluding post-
central gyrus), occipital, cerebellar, and medullopontine ar-
eas were statistically unremarkable. No lower absolute QSM 
Figure 3: Cluster-enhanced quantitative susceptibility mapping (QSM) group statistics in 28 patients with amyotrophic lateral 
sclerosis (ALS) versus 39 elderly control subjects. Age-corrected absolute QSM was greater in patients than in control subjects. 
Red/yellow clusters = statistical differences at a family-wise error (FWE) P value of less than .05, which are overlaid onto the 
study-wise QSM template in the Montreal Neurologic Institute I152 coordinate system. High QSM appears as hypointensity 
(dark areas). (Although some past studies have opted to depict high QSM values as bright, the present scheme was chosen to 
be consistent with the susceptibility-weighted convention of depicting strong susceptibility weighting as dark.)
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6 0.012 in GP; QSM = 0.148 ppm 6 0.021 in SN) than for 
limb-onset ALS (QSM = 0.084 ppm 6 0.014 in GP; QSM = 
0.130 ppm 6 0.019 in SN) and, in the GP only, for female 
patients (QSM = 0.095 ppm 6 0.014) versus male patients 
(QSM = 0.081 ppm 6 0.014). Sex effects were absent in con-
trol subjects for any ROI (P . .1). Such exploratory investiga-
tions revealed SN and GP QSM associations for all subgroups 
(limb: r2 = 0.26, P = .03; bulbar: r2 = 0.81, P = .001; male: r2 
= 0.50, P = .001; female: r2 = 0.45, P = .02).
Post-hoc Spearman correlation tests investigating the co-
variance between age-adjusted QSM values and ALS clinical 
scores (controlling for disease-onset type and sex differences in 
the SN and GP) were all negative (SN: r2ALSFRS-R = 0.06, P = .3, 
r2ECAS = 0.11, P = .1; GP: r
2
ALSFRS-R = 0.01, P = .7, r
2
ECAS = 0.04, 
P = .4; red nucleus: r2ALSFRS-R = 0.01, P = .8, r
2
ECAS = 0.05, P = 
.3; motor cortex: r2ALSFRS-R = 0.01, P = .9, r
2
ECAS = 0.09, P = .1; 
CST: r2ALSFRS-R = 0.03, P = .5, r
2
ECAS = 0.01, P = .6; and left pars 
opercularis: r2ALSFRS-R = 0.01, P = .8, r
2
ECAS = 0.03, P = .4).
Given the unexpected behavior of lower QSM in the ALS 
CST, a further correlation analysis was performed to test 
whether this effect could be driven by QSM-inversion residu-
als emanating from the adjacent GP; the result was negative 
(r2 = 0.05, P = .3).
P = .003) and particularly in the red nucleus (Z = 3.6, P < .001) 
and right pars opercularis (Z = 3.9, P < .001) were also higher in 
patients with ALS. More subtle effects, however, were observed 
in the putamen (Z = 2.0, P = .04) and hippocampus (Z = 2.1, P 
= .04), while a reversed pattern (lower QSM in ALS) was found 
in the CST (Z = –2.6, P = .01). In contrast, the dentate nucleus 
(Z = 1.6, P = .1), the caudate nucleus (Z = 0.7, P = .5), the amyg-
dala (Z = 0.8, P = .4), and the left pars opercularis (Z = 1.7, P = 
.09) remained relatively unchanged.
Magnified views of affected structures demonstrated 
QSM abnormalities that were apparent at visual inspection 
in most individual patients in contrast to matched control 
subjects (Fig 5). Visual inspection of the data also suggested 
that QSM for the SN and GP appeared to be covarying with 
each other in ALS. Formal investigation of this observation 
by using a Spearman rank-correlation test indeed confirmed 
that age-corrected SN and GP QSM values were moderately 
correlated (r2 = 0.42, P < .001) in ALS, whereas no such cor-
relation was evident in control subjects (r2 = 0.07, P = .1).
We subsequently investigated whether such a relationship 
held true for disease-onset type and sex-specific patient sub-
groups on the basis that age-adjusted QSM values were greater 
in GP and SN ROIs for bulbar-onset  ALS (QSM = 0.095 ppm 
Figure 4: Bar graph shows age-adjusted signed quantitative susceptibility mapping group statistics. Summary statistics are means 6 standard 
errors of the mean. Asterisks = the strength of the group difference—that is, ∗ = P , .05; ∗∗ = P , .01; ∗∗∗ = Bonferroni-corrected P , .05; and 
∗∗∗∗ = Bonferroni-corrected P , .01. ALS = amyotrophic lateral sclerosis, L = left, ppm = parts per million, R = right, SN = substantia nigra.
Acosta-Cabronero et al
Radiology: Volume nn: Number n—n 2018  n  radiology.rsna.org 7
in the CST; the magnitude of this decrease was correlated with 
DTI metrics such as fractional anisotropy in this tract.
QSM increase indicative of increased iron concentration in 
the primary motor cortex was an expected result in light of post-
mortem reports of Betz cell loss (23), intraneuronal TDP-43 
immunoreactivity (3) and, most notably, ferritin-positive mi-
croglia and macrophages (24,25). Such studies suggest primar-
ily that motor cortex neuronal and glial pTDP-43 inclusions are 
one of the earliest pathologic events in ALS and colocalize with 
iron-laden reactive microglia. Several MRI parameters have cap-
tured abnormalities in the motor cortex of ALS, namely, fluid- 
attenuated inversion recovery imaging (8,25), apparent trans-
verse relaxation time (T2*) (25,26), and, more recently, sus-
ceptibility-weighted imaging (24). In ROI studies, MR mea-
surements such as QSM (8,26) and MR spectroscopy (27) 
Finally, our correlation study investigating the covariance of 
QSM and DTI metrics in the CST revealed a positive effect for 
QSM and fractional anisotropy (r2 = 0.25, P = .007) and a nega-
tive effect for QSM and radial diffusivity (r2 = 0.25, P = .007) 
and QSM and mean diffusivity (r2 = 0.25, P = .007), while the 
QSM and axial diffusivity correlation was not significant (r2 = 
0.01, P = .7).
Discussion
This study identified evidence for increased tissue iron loading 
in ALS in several brain regions, most notably the motor cortex, 
SN, GP, red nucleus, and putamen. The increased iron concen-
tration in the SN and GP appeared to be occurring in concert 
in that the values for these regions were correlated in the ALS 
group. Lower magnetic susceptibility, meanwhile, was identified 
Figure 5: Representative sagittal, coronal, and axial quantitative susceptibility mapping (QSM) views in standard space in, A, five control sub-
jects and, B, five age-matched patients with amyotrophic lateral sclerosis (ALS). Arrowheads = some regions of QSM increase in ALS: precentral 
gyrus (all views), corpus striatum (sagittal view), and mesencephalon (coronal view). ALSFRS-R = ALS Functional Rating Scale Revised, F = female, 
M = male, y.o. = years old.
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the QSM results. This observation suggests that QSM, over-
all, is more sensitive than conventional structural MRI for de-
tecting abnormalities in ALS and could also be an indication 
that QSM might be revealing an upstream event of cell loss.
Furthermore, the correlation between nigral and pallidal QSM 
in ALS suggests that these two structures are affected in con-
cert by iron accumulation. Finally, there was a weak effect in 
the hippocampus, in keeping with structural imaging findings in 
this region in ALS (29); the effect size, however, was very small, 
particularly considering that hippocampal QSM values are very 
small in the control population.
Our study had some limitations. First, QSM values were not 
normalized to a reference region, which might have introduced 
spurious variability. Second, we were unable to establish QSM 
correlates of clinical severity measures. However, given the nar-
row spread of severity scores for our patient cohort and a rela-
tively low number of subjects for regression analyses, the risk of 
false-negative associations was very high. This is an important 
caveat of our study. Further studies with greater statistical power 
and greater spread of clinical severity scores (as well as complete 
genetic profiling) will be required to definitively address this 
issue. Our results might have also benefited from controlling for 
potential disease-onset type and sex in the patient population. A 
final limitation is that there was no postmortem measurement 
of regional brain iron concentration in the study population to 
confirm that this was definitely the cause of increased QSM val-
ues; however, the known regional variations in brain iron con-
centration from postmortem measurements agree very closely 
with that previously seen using the QSM method (14).
In conclusion, increased QSM values consistent with iron 
accumulation in ALS involved the motor cortex and a range 
of subcortical nuclei. This distribution is consistent with the 
known pattern of degeneration. Interestingly, qualitatively dif-
ferent QSM patterns are emerging in the major neurodegen-
erative diseases—eg, ALS in the present study, Parkinson disease 
(18), and Alzheimer disease (35)—that might offer insights for 
pathologic mechanisms beyond the standard distribution of his-
topathologic inclusions.
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have further characterized these effects, with indications that 
QSM might be a sensitive marker of motor cortex pathology 
in ALS (8). Our results extend these findings in demonstrating 
that QSM abnormalities in the motor cortex of ALS are now 
detectable with an unbiased whole-brain method. Meanwhile, 
PET imaging studies have demonstrated microglial activation 
in ALS, with one of the principal loci being the motor cortex 
(28). Increased QSM values in patients with ALS compared 
with control subjects consistent with iron accumulation sug-
gest a proactive role for metals in oxidative stress–induced cell 
death and, possibly, pTDP-43 accumulation (4); excess iron 
found in microglia might be due to phagocytosis of degenerat-
ing iron-containing neurons and glial cells (25).
Cortical QSM increases in patients with ALS compared 
with control subjects beyond the primary motor area were 
almost exclusively restricted to frontal regions, with the 
largest cluster extensively involving the inferior frontal cor-
tex but spreading across several other frontal areas. These 
results are concordant with other ALS imaging findings in 
showing that extramotor involvement, when present, has a 
characteristic frontal predilection for cortical atrophy (29), 
white matter disruption (22), glucose hypometabolism 
(30), and microglial activation (28).
Axonal efferents from the motor cortex pass into the CST. 
Previous longitudinal DTI work in ALS demonstrated that de-
generation in the CST, as measured by decline in fractional 
anisotropy, is essentially linear and, furthermore, is more sensi-
tive to change than motor cortex atrophy (31). It appears that 
QSM is also sensitive to CST degeneration. Our study found 
that QSM values in ALS were correlated with DTI parameters 
in this tract. Interestingly, however, susceptibility values in the 
ALS CST were in the opposite direction from those observed 
for gray-matter structures. That is, more negative than in con-
trol subjects, indicating a shift toward greater diamagnetism, 
the magnitude of which was correlated with DTI metrics. The 
mechanism underlying this diamagnetic shift is unclear. It is 
unlikely iron accumulation or demyelination could have driven 
this effect; however, these cannot be ruled out because the ex-
act contributions driving susceptibility polarity in white matter 
are still unclear because of inconsistencies between theoretical 
models and empirical data (32). However, the correlations with 
diffusion metrics argue strongly against this being a spurious 
finding and suggest that changes in the CST with QSM in 
some way reflect altered tissue microstructure (33).
Beyond the pyramidal system, several subcortical struc-
tures relevant to motor function showed higher QSM in ALS, 
namely, the SN, GP, putamen, and red nucleus. Subclinical 
involvement of the nigrostriatal pathway has also been previ-
ously demonstrated by using 6-fluorodopa PET (34), while 
the red nucleus is one first sites of pTDP-43 pathology af-
ter the primary motor nuclei (3). Interestingly, a volumetric 
study (29) focusing on subcortical structures found signifi-
cant group-level atrophy in several striatal nuclei for patients 
with advanced ALS with comorbid behavioral variant FTD 
but not in patients with mild or no cognitive impairment. 
The results of our deep-brain volumetry study in ALS with-
out dementia were also negative, standing in stark contrast to 
Acosta-Cabronero et al
Radiology: Volume nn: Number n—n 2018  n  radiology.rsna.org 9
lated to the present article: disclosed no relevant relationships. Activities not related 
to the present article: has received royalties from Thieme Publishing House. Other 
relationships: disclosed no relevant relationships. S.V. disclosed no relevant relation-
ships. P.J.N. disclosed no relevant relationships.
References
 1. Lomen-Hoerth C, Murphy J, Langmore S, Kramer JH, Olney RK, Miller B. Are 
amyotrophic lateral sclerosis patients cognitively normal? Neurology 2003;60(7): 
1094–1097.
 2. Neumann M, Sampathu DM, Kwong LK, et al. Ubiquitinated TDP-43 in fron-
totemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006; 
314(5796):130–133.
 3. Brettschneider J, Del Tredici K, Toledo JB, et al. Stages of pTDP-43 pathology in 
amyotrophic lateral sclerosis. Ann Neurol 2013;74(1):20–38.
 4. Lovejoy DB, Guillemin GJ. The potential for transition metal-mediated neurode-
generation in amyotrophic lateral sclerosis. Front Aging Neurosci 2014;6:173.
 5. Wang Q, Zhang X, Chen S, et al. Prevention of motor neuron degeneration by novel 
iron chelators in SOD1(G93A) transgenic mice of amyotrophic lateral sclerosis. 
Neurodegener Dis 2011;8(5):310–321.
 6. Jeong SY, Rathore KI, Schulz K, Ponka P, Arosio P, David S. Dysregulation of iron 
homeostasis in the CNS contributes to disease progression in a mouse model of 
amyotrophic lateral sclerosis. J Neurosci 2009;29(3):610–619.
 7. Wang Y, Liu T. Quantitative susceptibility mapping (QSM): decoding MRI data for 
a tissue magnetic biomarker. Magn Reson Med 2015;73(1):82–101.
 8. Schweitzer AD, Liu T, Gupta A, et al. Quantitative susceptibility mapping of the 
motor cortex in amyotrophic lateral sclerosis and primary lateral sclerosis. AJR Am J 
Roentgenol 2015;204(5):1086–1092.
 9. Chiò A, Calvo A, Moglia C, Mazzini L, Mora G; PARALS study group. Phenotypic 
heterogeneity of amyotrophic lateral sclerosis: a population based study. J Neurol 
Neurosurg Psychiatry 2011;82(7):740–746.
 10. Schreiber S, Abdulla S, Debska-Vielhaber G, et al. Peripheral nerve ultra-
sound in amyotrophic lateral sclerosis phenotypes. Muscle Nerve 2015;51(5): 
669–675.
 11. Brooks BR, Miller RG, Swash M, Munsat TL; World Federation of Neurology Re-
search Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for 
the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor 
Neuron Disord 2000;1(5):293–299.
 12. Rascovsky K, Hodges JR, Knopman D, et al. Sensitivity of revised diagnostic cri-
teria for the behavioural variant of frontotemporal dementia. Brain 2011;134(Pt 
9):2456–2477.
 13. Walsh DO, Gmitro AF, Marcellin MW. Adaptive reconstruction of phased array MR 
imagery. Magn Reson Med 2000;43(5):682–690.
 14. Acosta-Cabronero J, Betts MJ, Cardenas-Blanco A, Yang S, Nestor PJ. In vivo 
MRI mapping of brain iron deposition across the adult lifespan. J Neurosci 
2016;36(2):364–374.
 15. Schofield MA, Zhu Y. Fast phase unwrapping algorithm for interferometric applica-
tions. Opt Lett 2003;28(14):1194–1196.
 16. Schweser F, Deistung A, Lehr BW, Reichenbach JR. Quantitative imaging of intrin-
sic magnetic tissue properties using MRI signal phase: an approach to in vivo brain 
iron metabolism? Neuroimage 2011;54(4):2789–2807.
 17. Liu T, Wisnieff C, Lou M, Chen W, Spincemaille P, Wang Y. Nonlinear formula-
tion of the magnetic field to source relationship for robust quantitative susceptibility 
mapping. Magn Reson Med 2013;69(2):467–476.
 18. Acosta-Cabronero J, Cardenas-Blanco A, Betts MJ, et al. The whole-brain pattern 
of magnetic susceptibility perturbations in Parkinson’s disease. Brain 2017;140(1): 
118–131.
 19. Betts MJ, Acosta-Cabronero J, Cardenas-Blanco A, Nestor PJ, Düzel E. High- 
resolution characterisation of the aging brain using simultaneous quantitative sus-
ceptibility mapping (QSM) and R2* measurements at 7T. Neuroimage 2016;138: 
43–63.
 20. Jack CR Jr, Twomey CK, Zinsmeister AR, Sharbrough FW, Petersen RC, Cascino 
GD. Anterior temporal lobes and hippocampal formations: normative volumetric 
measurements from MR images in young adults. Radiology 1989;172(2):549–
554.
 21. Cardenas-Blanco A, Machts J, Acosta-Cabronero J, et al. Central white matter 
degeneration in bulbar- and limb-onset amyotrophic lateral sclerosis. J Neurol 
2014;261(10):1961–1967.
 22. Kasper E, Schuster C, Machts J, et al. Microstructural white matter changes underly-
ing cognitive and behavioural impairment in ALS--an in vivo study using DTI. PLoS 
One 2014;9(12):e114543.
 23. Udaka F, Kameyama M, Tomonaga M. Degeneration of Betz cells in motor neuron 
disease. A Golgi study. Acta Neuropathol (Berl) 1986;70(3-4):289–295.
 24. Adachi Y, Sato N, Saito Y, et al. Usefulness of SWI for the detection of iron in the 
motor cortex in amyotrophic lateral sclerosis. J Neuroimaging 2015;25(3):443–451.
 25. Kwan JY, Jeong SY, Van Gelderen P, et al. Iron accumulation in deep cortical layers 
accounts for MRI signal abnormalities in ALS: correlating 7 tesla MRI and pathol-
ogy. PLoS One 2012;7(4):e35241.
 26. Costagli M, Donatelli G, Biagi L, et al. Magnetic susceptibility in the deep lay-
ers of the primary motor cortex in amyotrophic lateral sclerosis. Neuroimage Clin 
2016;12:965–969.
 27. Pyra T, Hui B, Hanstock C, et al. Combined structural and neurochemical evalu-
ation of the corticospinal tract in amyotrophic lateral sclerosis. Amyotroph Lateral 
Scler 2010;11(1-2):157–165.
 28. Turner MR, Cagnin A, Turkheimer FE, et al. Evidence of widespread cerebral mi-
croglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron 
emission tomography study. Neurobiol Dis 2004;15(3):601–609.
 29. Machts J, Loewe K, Kaufmann J, et al. Basal ganglia pathology in ALS is associated 
with neuropsychological deficits. Neurology 2015;85(15):1301–1309.
 30. Quartuccio N, Van Weehaeghe D, Cistaro A, Jonsson C, Van Laere K, Pagani M. 
Positron emission tomography neuroimaging in amyotrophic lateral sclerosis: what 
is new? Q J Nucl Med Mol Imaging 2014;58(4):344–354.
 31. Cardenas-Blanco A, Machts J, Acosta-Cabronero J, et al. Structural and diffusion 
imaging versus clinical assessment to monitor amyotrophic lateral sclerosis. Neuro-
image Clin 2016;11:408–414.
 32. Duyn JH. Frequency shifts in the myelin water compartment. Magn Reson Med 
2014;71(6):1953–1955.
 33. Wharton S, Bowtell R. Effects of white matter microstructure on phase and suscep-
tibility maps. Magn Reson Med 2015;73(3):1258–1269.
 34. Takahashi H, Snow BJ, Bhatt MH, Peppard R, Eisen A, Calne DB. Evidence for a 
dopaminergic deficit in sporadic amyotrophic lateral sclerosis on positron emission 
scanning. Lancet 1993;342(8878):1016–1018.
 35. Acosta-Cabronero J, Williams GB, Cardenas-Blanco A, Arnold RJ, Lupson V, 
Nestor PJ. In vivo quantitative susceptibility mapping (QSM) in Alzheimer’s disease. 
PLoS One 2013;8(11):e81093.
